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ABSTRACT To the best of our knowledge, this is the ﬁrst report on the structure of product-inhibited mammalian peroxidase.
Lactoperoxidase is a heme containing an enzyme that catalyzes the inactivation of a wide range of microorganisms. In the
presence of hydrogen peroxide, it preferentially converts thiocyanate ion into a toxic hypothiocyanate ion. Samples of bovine
lactoperoxidase containing thiocyanate (SCN) and hypothiocyanate (OSCN) ions were puriﬁed and crystallized. The structure
was determined at 2.3-A˚ resolution and reﬁned to Rcryst and Rfree factors of 0.184 and 0.221, respectively. The determination of
structure revealed the presence of an OSCN ion at the distal heme cavity. The presence of OSCN ions in crystal samples was
also conﬁrmed by chemical and spectroscopic analysis. The OSCN ion interacts with the heme iron, Gln-105 N31, His-109 N32,
and a water molecule W96. The sulfur atom of the OSCN ion forms a hypervalent bond with a nitrogen atom of the pyrrole ring D
of the heme moiety at an S–N distance of 2.8 A˚. The heme group is covalently bound to the protein through two ester linkages
involving carboxylic groups of Glu-258 and Asp-108 and the modiﬁed methyl groups of pyrrole rings A and C, respectively. The
heme moiety is signiﬁcantly distorted from planarity, whereas pyrrole rings A, B, C, and D are essentially planar. The iron atom is
displaced byz0.2 A˚ from the plane of the heme group toward the proximal site. The substrate channel resembles a long tunnel
whose inner walls contain predominantly aromatic residues such as Phe-113, Phe-239, Phe-254, Phe-380, Phe-381, Phe-422,
and Pro-424. A phosphorylated Ser-198 was evident at the surface, in the proximity of the calcium-binding channel.INTRODUCTION
Lactoperoxidase (LPO, E.C.1.11.1.7) is a heme containing
az68-kDa single-chain glycoprotein. It belongs to mamma-
lian peroxidase superfamily whose other members are
myeloperoxidase (MPO), eosinophil peroxidase (EPO),
and thyroid peroxidase (TPO). Lactoperoxidase, MPO, and
EPO play important roles in strengthening the innate
immune system by catalyzing the conversion of halide or
thiocyanate ions into potent ions that are toxic to pathogens
(1–4). These peroxidases are widely present in mammalian
systems. Myeloperoxidase is found in granules of circulating
polymorphonuclear neutrophils and monocytes (2,3). Eosin-
ophil peroxidase is an important granule protein of eosino-
phils (4), whereas LPO is present in exocrine secretions. It
provides initial protection against harmful microorganisms
(1). Thyroid peroxidase is a different member of the family
that plays a critical role in thyroid gland function (5).
Lactoperoxidase oxidizes the conversion of halide and pseu-
dohalide ions into potent antimicrobial agents, and thus
contributes to the host defense against infections. So far,
structural data are available only on MPO (6–8). Crystalliza-
tion efforts on LPO are underway in several laboratories
throughout the world, but these have been largely unsuccess-
ful. Only very recently was the crystal structure of caprine
lactoperoxidase (GLPO) reported (9). However, a decade
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was reported (10). The complex catalytic mechanisms in-
volving peroxidases are not fully understood. The structural
and chemical basis of preferences for various substrates has
also not been explained clearly. Therefore, it is of the utmost
importance to determine the crystal structure of LPO from
different mammalian species in native and bound forms
with various ligands. It is known that many enzymes are in-
hibited by their products (11). However, no such structure is
known for mammalian peroxidases. We report here on the
crystal structure of the complex of bovine lactoperoxidase
(CLPO) with the CLPO-catalyzed reaction product, the hy-
pothiocyanate (OSCN) ion. The determination of structure
revealed that the OSCN ion binds to CLPO at the distal
heme cavity. It is oriented in such a way that the oxygen
atom of the OSCN ion forms a strong interaction with
heme iron. The same oxygen atom is also involved in two
other hydrogen bonds with Gln-105 and His-109. The bind-
ing of the OSCN ion to CLPO induces a notable conforma-
tional change in the heme group, compared with the native
conformation of GLPO (9). The hydrogen-bonded chain of
five buried water molecules, W2–W6, is conserved. The
shape of the ligand-binding channel is also slightly altered.
The presence of phosphorylated Ser-198 and the SCN ion
at the entrance of channel leading to the calcium-binding
site produces favorable conditions for calcium absorption.
doi: 10.1016/j.bpj.2008.09.019
MATERIALS AND METHODS
Puriﬁcation of the protein
Crude CLPO was obtained from Morinaga (Tokyo, Japan). It was dissolved
in 50 mM Tris-HCl, pH 8.0, to make a final concentration of 10 mg/mL. The
sample was loaded on a CM-Sephadex C-50 (Pharmacia, Uppsala, Sweden)
column (10  2.5 cm) preequilibrated with 50 mM Tris-HCl, pH 8.0. The
elution of LPO was performed with a linear gradient of 0.0–0.5 M NaCl
in the same buffer. The protein fractions of Rz value 0.79 or higher were
pooled and concentrated, using an Amicon ultrafiltration cell (Millipore,
Billerica, MA). The concentrated protein sample was passed through a
Sephadex G-100 column (100  2 cm), using 50 mM Tris-HCl buffer,
pH 8.0. The elution was performed at a flow rate of 6.0 mL/h. The fractions
of an Rz value of 0.93 or higher were pooled and dialyzed against deionized
water, lyophilized, and stored at 253 K. Protein samples were examined after
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
and compared with standard molecular-weight markers. This examination
revealed a single band on the SDS-PAGE that corresponded to a molecular
mass of ~68 kDa. It was blotted on a polyvinyl difluoride membrane (Sigma-
Aldrich, St. Louis, MO), and was used for N-terminal sequence determina-
tion on an automated protein sequencer (PPSQ 21, Shimadzu, Kyoto,
Japan). The N-terminal sequence of first 20 residues was obtained as Ser-
Trp-Glu-Val-Gly-Cys-Gly-Ala-Pro-Val-Pro-Leu-Val-Thr-Cys-Asp-Glu-
Asn-Ser-Pro. It matched with the reported sequence of bovine LPO (12).
Detection of OSCN ion
To confirm the presence of the OSCN ion in the present structure, crystals
of the CLPO complex with the OSCN ion were used. First of all, crystals
were washed with distilled water and dissolved in normal protein buffer. The
solution was incubated with 1 M NaCl for 1 h, and then ultrafiltered using
a membrane with a 1-kDa cutoff. The concentration of OSCN ions in
the filtrate was estimated by the oxidation of 2 mol of 5-thio 2-nitrobenzoic
acid (NBS) to the disulfide compound 5,50-dithiobis (2-nitrobenzoic acid)
(NBS2) by 1 mol of OSCN ion (13). The reduction in concentration of
NBS after mixing it with the filtrate was determined by the decrease in ab-
sorbance at 412 nm, using a spectrophotometer (Perkin-Elmer, Boston,
MA), and considering a molar absorption coefficient of 13,600 M1 cm1
for NBS (14).
Spectroscopic analysis of CLPO
The spectral changes in heme absorbance at 412 nm were determined for
three protein preparations. The first solution was prepared by dissolving pro-
tein crystals in distilled water. The second solution was prepared as OSCN
ion free protein by incubating the first solution with 1 M NaCl and ultrafil-
tering it using a membrane with a 1-kDa cutoff. The third solution was made
by adding 1 mM KSCN and 0.2 mM H2O2 in 10 mM potassium phosphate
buffer, pH 6.6, to the protein solution (15).
Measurement of activity
The activity assay of the protein sample obtained by dissolving crystals of
0.1 M phosphate buffer, pH 7.0, was performed using the procedure de-
scribed by Kumar et al. (10). We mixed 3.0 mL of 1 mM 2,20-azino-
bis(3-ethylbenzthiazoline-sulfonic acid, ABTS) in phosphate buffer (0.1 M,
pH 6.0) with 0.1 mL of 0.5 mg/mL protein solution containing 0.1% gelatin,
to initialize the spectrophotometer (Perkins Elmer). We added 0.1 mL of
3.2 mM hydrogen peroxide to the above solution. Absorbance was measured
at 412 nm as a function of the oxidized product of ABTS. There was no
change in absorbance. One unit of activity was defined as that amount of en-
zyme catalyzing the oxidation of 1 mmol of ABTS min1 at 293 K (molar
absorption coefficient, 32,400 M1 cm1). The protein samples obtained
from the crystals were dialyzed in the presence of 1 M NaCl. These were
Structure of Lactoperoxidase Complexalso used for the activity assay under identical conditions. This sample
showed a significant peroxidase activity of 6.0 units/mL.
Phosphoserine detection
The purified sample of LPO was processed on SDS-PAGE, using 10% poly-
acrylamide gel as described by Laemmli (16). The protein was transferred
from SDS-PAGE to a polyvinyl difluoride membrane (Sigma-Aldrich) by
Western blotting, and nonspecific binding sites were blocked for 2–4 h at
room temperature, using 5% dried milk and Tris-buffered saline (pH 7.4)
and 0.1% Tween-20. The membrane was probed overnight at 4C with pri-
mary antiphosphoserine antibody (17) (1:5000) for the serine phosphoryla-
tion site in CLPO. A secondary horseradish peroxidase-labeled antibody
raised in rabbit (goat anti-rabbit IgG, Jackson Immunochemicals, West
Baltimore Pike, West Grove, PA), in combination with an enhanced chem-
iluminescence detection system (Super Signal West Pico Chemiluminescent
Substrate, Thermo Fisher Scientific, Waltham, MA), was used to visualize
the primary antibodies.
Crystallization
The purified samples of protein were dissolved in 0.01 M phosphate buffer
to a concentration of 25 mg/mL. A reservoir solution containing 0.2 M of
ammonium nitrate and 20% (w/v) PEG-3350 was prepared. Six microliters
of protein solution were mixed with 6 mL of reservoir solution, to prepare
12 mL of drops for the hanging drop vapor diffusion method. Rectangular
dark brown crystals, measuring up to 0.4  0.3  0.2 mm3, were obtained
after 5 days.
X-ray intensity data collection
The X-ray intensity data were collected at 283 K, using a 345 mm diameter
MAR Research dtb imaging plate scanner (Marresearch, Norderstedt,
Germany) mounted on a Rigaku RU-300 rotating anode x-ray generator
(Rigaku) operating at 100 mA and 50 kV. The CuKa radiation was produced
using Osmic Blue confocal optics (Rigaku). The data were processed using
the programs DENZO and SCALEPACK (18). The space group and unit
cell dimensions were P21 and a ¼ 54.5 A˚, b ¼ 80.6 A˚, c ¼ 77.6 A˚,
and b ¼ 102.6. The final data set shows an overall completeness of
99.3%, with an Rsym of 10% for data to 2.3-A˚ resolution. A summary of final
data-collection statistics is given in Table 1.
Structure determination and reﬁnement
The structure of the complex of bovine LPO with the hypothiocyanate ion
was determined according to the molecular replacement method, using the
principle of maximum likelihood in PHASER (19). The native GLPO struc-
ture (9) was used as the search model using Protein Data Bank code 2R5L.
The rotation and translation search functions were computed using the re-
flections in a resolution range of 12.0–4.0 A˚. It yielded a clear solution
with a distinct peak of minimum R value and maximum correlation coeffi-
cient. The molecular packing in the unit cell, calculated according to this
solution, did not produce unfavorable short contacts. The coordinates
were transformed using PHASER, and were subjected to 25 cycles of rigid
body refinement with REFMAC (20) from the CCP4i version 6.0.0 program
package (21). After the first round of refinement, the Rcryst and Rfree factors
reduced to 0.326 and 0.412, respectively (5% of the reflections were used for
the calculations of Rfree; these reflections were not included in the refine-
ment). The initial Fourier (j2Fo  Fcj) and difference Fourier (jFo  Fcj)
maps showed good electron densities for the heme group. The coordinates
of the heme group were included in further rounds of refinement that were
performed with the intermittent manual model building of the protein, using
j2Fo  Fcj Fourier and jFo  Fcj difference Fourier maps, with graphics
programs O (22) and coot (23), on a Silicon Graphics O2 Workstation
(Sunnyvale, CA). At the end of this refinement, the Rcryst and Rfree factors
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converged to 0.248 and 0.278, respectively. The difference Fourier map cal-
culated at this stage revealed interpretable electron densities for glycan
chains at four sites, with two N-acetylglucosamine (NAG) residues and
one mannose (MAN) at Asn-95, two NAG residues at Asn-205, two NAG
þ one MAN residues at Asn-241, and two NAG residues at Asn-332. Excel-
lent electron densities were also evident at the distal heme cavity for the OS-
CN ion (Fig. 1 a) and SCN ion at the surface in the proximity of Arg-202
(Fig. 1 b), as well as for the calcium ion. A further detailed examination of
the electron density maps revealed additional electron densities for five ni-
trate ions. All of these were included in subsequent rounds of refinement.
Further difference jFo – Fcj Fourier maps indicated additional electron den-
sities for the phosphorylation of Ser-198. The positions of 413 water oxygen
atoms were determined using the usual criteria of correctness. The refine-
ment finally converged with Rcryst and Rfree values of 0.184 and 0.221, re-
spectively. The final refinement statistics are included in Table 1. The refined
atomic coordinates of this complex were deposited in the Protein Data Bank,
with an accession code 3BXI.
TABLE 1 Data collection and reﬁnement statistics
Data collection
Space group P21
Unit cell dimensions 54.5
a (A˚) 80.6
b (A˚) 77.6
c (A˚) 102.6
b ()
Number of molecules in the unit cell 2
Vm (A˚
3/Da) 2.5
Solvent content (%) 52
Resolution range (A˚) 24.5–2.3
Total number of measured reflections 154,457
Number of unique reflections 27,641
Completeness of data (%) 99.3 (99.4)
Refinement
Rsym (%) 10.0 (46.3)
I/s(I) 9.1 (2.2)
Rcryst (%) 18.4
Rfree (%) (reflections used, 1477) 22.1
Coordinate error from Luzzati plot 0.2
Coordinate error from Sigmaa 0.2
Protein atoms 4774
Calcium ion 1
Hypothiocynate (1) atoms 4
Thiocyanate (1) atoms 3
NAG residues (8) (N-linked) 112
MAN residues (2) (N-linked) 22
Water oxygen atoms 413
Rmsd in bond lengths (A˚) 0.009
Rmsd in bond angles () 1.7
Rmsd in torsion angles () 18.8
Average B-factor (A˚2)
Overall 28.3
Main chain 26.3
Side chain 27.3
Solvent 38.1
Wilson 27.1
Residues in most favored regions (%) 89.4
Residues in additionally allowed regions (%) 10.2
Residues in generously allowed regions (%) 0.4
Protein Data Bank code 3BXI
Values in parentheses correspond to values in highest resolution shell.
Rmsd, root mean-square deviation.
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OSCN ion in crystals
Oxidation of NBS to NBS2 in the filtrate obtained from crys-
tal solution confirmed the presence of the OSCN ion in the
crystals. The concentration of OSCN ion was estimated to
be 0.1 mM. Because LPO contains a heme group at the active
center, the change in absorption of heme with regard to
ligand-binding is the indication of interactions involving
heme moiety. Spectral studies were performed of CLPO
crystal solution, OSCN ion free solution, and crystal solu-
tion containing OSCN ions. The heme absorption at 412 nm
showed identical values with the spectral curves, superim-
posing well for the samples of crystal solution and protein
solution with OSCN ions. However, the measurements of
OSCN ion free samples showed different values, and the
absorption curve did not superimpose on the spectral curves
obtained for the OSCN containing protein solutions. It con-
firmed the presence of OSCN ions in the crystals.
Quality of the model
The final model (summarized in Table 1) comprises amino-
acid residues from 1–595, corresponding to the complete
polypeptide chain of LPO. The entire protein molecule is
well-defined in the observed electron density. The structure
consists of a covalently linked heme group, one calcium,
five nitrate, one thiocyanate, and one hypothiocyanate ions,
four glycan chains, and 413 water oxygen atoms. The overall
mean B-factor of CLPO is 28.3 A˚2, comparable to those ob-
served for other well-refined protein structures (7–9). A
Ramachandran plot (24) of the polypeptide chain torsion an-
gles with various allowed regions, as defined in the program
PROCHECK (25), shows that 89.4% of residues are present
in the most favored regions, whereas 10.2% of residues were
found in the additionally allowed regions. Only two residues,
Thr-169 and Tyr-172, occur in the generously allowed re-
gions. Both residues belong to a short loop that is involved
in an extraordinary intramolecular disulfide bridge between
Cys-6 and Cys-167. This intramolecular S-S bond is not
present in MPO, because residue Cys-6 is absent.
Overall structure
The determination of crystal structure shows that a hypothio-
cyanate ion is present at the distal heme cavity. The presence
of OSCN ions in the crystals was also indicated by spectro-
scopic measurements. The determination of structure also
revealed an SCN ion at the surface, in the proximity of
Arg-202. The folding of the polypeptide chain of CLPO is
essentially similar to that of GLPO (9). The root mean-square
(rms) shift for the Ca traces of two proteins is 0.6 A˚. The mo-
lecular organization, together with four glycan chains, the
heme group, and a bound OSCN ion, is shown as a ribbon
diagram (Fig. 2). The structure shows that the heme group is
sandwiched between two antiparallel helices, H2 and H8.
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FIGURE 1 (a) OSCN fitted into 2.5
s (jFo Fcj) electron density. The heme
group and distal Gln-105 and His-109
are also shown. (b) SCN fitted into
2.5 s (jFo  Fcj) electron density. Res-
idues in the vicinity are also indicated.
Structure of Lactoperoxidase Complex 649The perpendicular distance between the backbone atoms of
helices H2 and H8 is increased by 0.4 A˚ in the complex
with the OSCN ion, compared with the native structure
FIGURE 2 Schematic diagram of bovine lactoperoxidase complex with
OSCN ion, indicating positions of a-helices (cylinders 1–19), heme moiety
(green online and medium gray in print), hypothiocyanate ion, and glycan
chains (yellow online and light gray in print). Side chains of Asn-95, Asn-
205, Asn-241, and Asn-332, covalently linked to glycan chains, are also
shown. Figure was drawn using Pymol (39).of CLPO. The central core of the molecule contains five
long a-helices (H2, H5, H6, H8, and H12), with a covalently
attached heme group. The first 75 residues of the N-terminus
adopt a flexible nonrepetitive structure. Because of the flex-
ible nature of the N-terminal segment, the rms shift for the Ca
atoms of the first 75 residues of CLPO and GLPO is 1.3 A˚,
i.e., considerably higher than the overall rms shift calculated
using all the residues. As seen in Fig. 2, the heme group lies
below the triangle formed by helices H2, H5, and H6. A
narrow opening is evident from the heme group to the sur-
face of the protein. One side of this channel is composed of
helices H8, H11, H12, and H2a, whereas the other side con-
tains helices H2, H3, H4, and H9. The helix H2a is not
present in MPO. This channel is used for the diffusion of
substrates into the protein core where the heme is located.
This is the only opening evident in the structure, insofar
as all other sides are tightly packed. Helix H2a (residues
123–132) is a unique feature of LPO and is not possible
in the structure of MPO, because the corresponding protein
stretch of six residues is absent in the sequence of MPO
(6–8). Because this helix is located at the entrance of the
substrate-binding channel, it contributes to the overall shap-
ing of the substrate channel in LPO. As a result, the shape
of the substrate channel in LPO is considerably different
from that of MPO (6–8). The structure of LPO also shows
that the lower half of the molecule is packed with short
horizontal helices, whereas the upper half contains vertical
helices.
Binding of OSCN
Lactoperoxidase catalyzes the reaction of hydrogen peroxide
with thiocyanate, and produces the OSCN ion, which is
toxic to various pathogens. The lactoperoxidase system
(LPO-H2O2) is a natural antimicrobial system present in
mammalian secretions, including milk. Thiocyanate
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(SCN) ions are also present in the milk as a result of the hy-
drolysis of glucosinolates, as well as from the detoxification
of cynogenic glucosides (26). The H2O2 is either supplied
exogenously or generated by lactic-acid bacteria, which are
also present in the milk (27). In the process of the reaction
of the LPO-system, H2O2 is consumed. The reduction in
the concentration of H2O2 in milk results in stopping the con-
version of SCN to OSCN. Therefore, samples of milk
generally contain both SCN and OSCN ions. Alternately,
OSCN ions could accumulate if the reactive components or
pathogens are not present in the milk. In this case, we
observed that an OSCN ion binds to LPO at the distal
site, thereby inhibiting its catalytic activity of the enzyme.
One bound SCN ion was also observed at the surface of
the protein in the vicinity of helix H3. The determination
of structure revealed the position of the OSCN ion at the
distal heme cavity, between the heme moiety and distal
His-109 (Fig. 3). The OSCN ion displaced at least three wa-
ter molecules from the substrate-binding site, including W1,
which interacts with the Fe3þ ion and His-109 N32 in the na-
tive structure (9). The OSCN ion interacts extensively at
this site, indicating it as the preferred binding site for the
OSCN ion. The oxygen atom of the OSCN ion forms
three hydrogen bonds: one with His-109 N32 (2.7 A˚), a sec-
ond with heme iron (2.7 A˚), and the third with Gln-105 N32
(3.1 A˚). Both nitrogen and sulfur atoms of the OSCN ion
form hydrogen bonds with W96 (S-W96 ¼ 2.8 A˚, and
N-W96 ¼ 3.3 A˚). Yet another important interaction was ob-
served between the S atom of the OSCN ion and the nitro-
gen atom of the pyrrole ring D of the heme moiety (S-ND ¼
2.8 A˚). This kind of hypervalent bond between sulfur and
nitrogen atoms was reported elsewhere (28,29). The binding
of the OSCN ion to the protein and the heme moiety dis-
turbed an important interaction between Gln105 N32 and
the heme nitrogen atom NA, as observed in the native struc-
ture, and stated to be one of the characteristic features of LPO
structure (9). In our complex under discussion, this distance
increased by 0.6 A˚, to 3.7 A˚. This shows that the binding of
the OSCN ion at the distal heme cavity, and the resulting
interactions between the OSCN ion and the protein heme
moiety, displaced three water molecules and several pro-
tein/water interactions with the heme moiety. This appears
to be the site of inhibition in LPO, and the binding character-
istics of the OSCN ion to LPO display all the features of
a competitive inhibitor. Thus the complex of LPO with the
OSCN ion is a complex between the enzyme and the inhib-
itor. Such types of product inhibitions were observed to
occur commonly in those enzymes that form highly reactive
intermediates (11). An SCN ion is also evident in the struc-
ture on the surface of the protein in the vicinity of helix H3. It
forms an ion pair with the side chain of Arg-202. This site was
reported to be occupied by an iodide ion in the native struc-
ture of GLPO (9). In contrast, the corresponding site is not
formed in MPO, because it contains Asn-186 in place of
Arg-202. The binding of the SCN ion at this position in
LPO may be structurally relevant, because this site of
SCN ion-binding is in close proximity to the phosphory-
lated Ser-198. The presence of the SCN ion presumably
neutralizes the positive charge on the Arg-202 side chain,
which might be helpful for the intake of calcium ions. These
features are in striking contrast to those present in the
structure of MPO (6–8).
Heme environment
The heme group is covalently bonded to protein through
modified methyl groups on pyrrole rings A and C and the
carboxyl groups of Glu-258 and Asp-108, respectively
(Fig. 4). The heme moiety is deeply buried in the protein
molecule, and also forms a number of noncovalent interac-
tions with the protein atoms. The four pyrrole rings A, B,
C, and D of protoporphyrin IX are planar, and the iron
atom is shifted by ~0.2 A˚ toward the proximal side from
the plane made by the nitrogen atoms of four pyrrole rings.
This shift is twice the corresponding shift (0.1 A˚) observed
in the native GLPO (9). The plane calculated using four
FIGURE 3 Electron density (jFo 
Fcj) for hypothiocyanate ion bound in
distal heme cavity, contoured at 2.5 s
level. Residues Gln-105 and His-109
on distal site and His-351 on proximal
site are also shown. Positions of a-heli-
ces H2 and H8 with respect to heme
group are also indicated. Two opposite
orientations (a and b) are shown for
clarity of interactions with OSCN ion.
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pyrrole nitrogen atoms and the heme iron atom shows that it
forms a bowl-like structure, with the iron atom at the bottom
of the bowl when viewed from the distal side. The lines con-
necting the nitrogen atoms of pyrrole rings A and C, and B
and D, are inclined toward the iron atom, with angles
:NA–Fe–NC and:NB–Fe–ND of 167.5 and 165.0, re-
spectively. The N32 atom of His-351 on the proximal site is
coordinated to the iron atom at a distance of 2.1 A˚, whereas
the Nd1 of this residue is hydrogen-bonded to the amide
carbonyl oxygen atom of Asn-437.
Distal heme cavity and substrate channel
The distal heme cavity plays a pivotal role in determining the
catalytic activity of LPO. This cavity is connected to the sur-
face through a narrow channel which is supported by the b,
g, and d carbon atoms of Arg-255 on one side, whereas side
chains of Phe-113, Pro-234, Phe-239, Phe-254, Phe-380,
Phe-381, Phe-422, and Pro-424 form the remaining sides
(Fig. 5). A notable feature of this structure pertains to the res-
idue Phe-254 in CLPO, which is a part of the channel wall.
It increases the hydrophobicity of the channel considerably.
The corresponding residue is threonine in MPO, whereas
both EPO and TPO have a glycine residue at the correspond-
ing position. The distal heme cavity is filled by the side
chains of residues Gln-105, His-109, and Arg-255. A chain
of five hydrogen-bonded buried water molecules and a side
chain of His-266 extend from the distal His-109 to the sur-
face of the protein molecule, presumably to conduct protons
away from the distal histidine, and ensuring that N32 is free to
accept a proton from hydrogen peroxide.
FIGURE 4 Electron density (j2Fo Fcj) for heme moiety contoured at 1.2
s level. Electron densities for residues Asp-108 and Glu-258, covalently
linked to the heme group, are also shown. Iron, oxygen, and nitrogen atoms
of the heme group are labeled. The four pyrrole rings are also labeled.
Structure of Lactoperoxidase ComplexCarbohydrate structure
The amino-acid sequence of bovine LPO reveals four poten-
tial N-glycosylation sites, with Asn-X-Ser/Thr sequence mo-
tifs. These are at Asn-95, Asn-205, Asn-241, and Asn-332
(12). The crystallographic analysis confirmed the glycan
attachments at all four sites, and the remarkably good quality
of electron densities at these sites enabled us to model at least
10 sugar residues. The electron densities are present for two
N-acetylglucosamine (NAG1 and NAG2) residues and a
b-1,4-mannose (MAN3) residue at Asn-95, for a disaccharide
comprising two NAG (NAG4 and NAG5) residues at Asn-
205, for a trisaccharide comprising two NAG (NAG6 and
NAG7) residues, and a b-1,4-mannose (MAN8) residue at
Asn-241, whereas a disaccharide with two NAG (NAG9
and NAG10) residues is attached to Asn-332. In MPO,
out of five potential glycosylation sites, only three were found
with attached glycan chains (6,7). The three glycosylated
sites in MPO are identical to the second, third, and fourth sites
in LPO. The glycosylation at Asn-95 is unique to LPO. Asn-
95 is located in a highly positive environment. In addition to
the covalent linkage with Asn-95, this carbohydrate moiety
forms two hydrogen bonds, with Arg-504 NH1 and
Gln-568 O31 involving acetamido oxygen atoms O7 of
FIGURE 5 View of substrate channel connecting distal heme cavity to
surface of protein. Positions of calcium and OSCN ions, and of His-109,
W2–W6, and His-266, are shown. Position of SCN ion is also indicated.
Channel walls contain predominantly hydrophobic residues, which are
also indicated.
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carbohydrate residues 1 and 2, respectively. Asn-95 is part of
an important helix H2 in the distal side, and supports the
heme environment. A well-anchored glycan chain at Asn-
95 contributes to the stability of helix H2. This is an important
difference between the structures of LPO and MPO that might
have some bearing on the properties of the heme group and on
the binding characteristics at the distal site.
DISCUSSION
The amino-acid sequences of four mammalian peroxidases
indicate that the mode of covalent binding to the heme moiety
with two covalent linkages in LPO is similar to those of EPO
and TPO, whereas MPO forms three covalent bonds with the
heme group, including two identical linkages with those of
LPO, EPO, and TPO. This is because residues Glu-258 and
Asp-108 form covalent bonds with the heme moiety, and
are conserved in all four mammalian peroxidases. A third co-
valent bond was observed only in MPO through sulfonium
ion linkage between the sulfur atom of Met-243 and the termi-
nal b-carbon of the vinyl group on pyrrole ring A. The other
three mammalian peroxidases lack the methionine residue at
the corresponding positions. The residues at these positions
in LPO, EPO, and TPO are Gln-259, Thr-242, and Val-361,
respectively. The structure of LPO (9) shows that Gln-259
is involved in an extensive hydrogen-bonded network with
Gln-102, Gln-105, and Leu-261 in the back of the distal
heme cavity. Gln-105 O31 forms two hydrogen bonds
with Gln-259 N32 and Gln-102 N32, whereas Gln-105 N32 is
involved in three hydrogen bonds: two as a donor with
Glu-25831 (3.1 A˚) and the heme pyrrole ring A nitrogen
atom (3.3 A˚), and the third as an acceptor with water molecule
W1 (2.8 A˚). The interaction between Gln-105 N32 and pyrrole
nitrogen atom NA is recognized as a feature unique to the LPO
structure, because the corresponding distance in MPO is 3.9 A˚
(6,7). In this regard, EPO with Thr-242 and TPO with Val-361
at the position of Gln-259 are expected to induce different
possibilities for interactions because of the conserved
glutamine residue corresponding to Gln-105 in LPO.
Therefore, protein-heme interactions are not identical in the
four mammalian peroxidases, because the residues corre-
sponding to Met-243 in MPO, LPO, EPO, and TPO have
different residues, i.e., Gln-259, Thr-242, and Val-361,
respectively.
In structure under discussion, the position of water mole-
cule W1 in the distal heme cavity is occupied by the oxygen
atom of the OSCN ion. It interacts with Gln-105, His-109,
and the heme iron (Fig. 3). The OSCN ion also forms a hy-
pervalent bond, with an S-N bond distance of 2.8 A˚ between
the sulfur atom of the OSCN ion and the nitrogen atom ND
of the heme group (28,29). This indicates tight binding be-
tween the enzyme and the OSCN ion, suggesting that it
is a potent inhibitor. The OSCN ion is a highly reactive
intermediate, and accumulates in the absence of other inter-
actable reactive components. As a result, it forms a stable
complex with LPO. Although its precise physiological sig-
nificance is not clearly understood, it was observed in a num-
ber of enzymes, particularly in the case of oxidases, where
highly reactive products are formed (11). Because the
OSCN ion is tightly held between the heme group from
one side and His-109, water molecule W96, Gln-105, and
Arg-255 from the other sides, it produces notable perturba-
tions in the positions of surrounding protein residues and
heme moiety. A noteworthy observation pertains to the
loss of an important interaction between Gln-105 N32 and
the heme nitrogen atom NA, as observed in the native
LPO structure (9). Other structures with small ions at the dis-
tal site, such as Cl (2QRB), I (2IPS), and PO4
2 (2EFB),
also show interactions between Gln-105 and the heme moi-
ety, whereas larger ligands such as salicylhydroxamic acid
(2QPK) and acetyl salicylic acid (2QQT) show distances be-
tween Gln-10532 and NA higher than 3.6 A˚, indicating the
absence of interactions between the side chain of Gln-105
and the heme group. Thus the binding of larger ligands in
LPO converts it to a form similar to that observed in native
MPO (6,7). The calculations also show that the heme moiety
FIGURE 6 Relative positions of (a)
OSCN ion in LPO and (b) SCN ion
in MPO. The bound water molecule
(W209) is present in MPO structure.
Corresponding water molecule is
displaced by OSCN ion in LPO. The
OSCN ion seems to bind more prefer-
entially than does the SCN ion.
Biophysical Journal 96(2) 646–654
652 Singh et al.
in the structure of LPO with the OSCN ion is considerably
more planar, compared with those observed in the structures
of LPO with Cl (2QRB), I (2IPS), and PO4
2 (2EFB). The
heme planarity observed in the present structure is compara-
ble to those observed in complexes with salicylhydroxamic
acid (2QPK) and acetyl salicylic acid (2QQT). These obser-
vations indicate that a tightly packed ligand with significant
interactions at the distal substrate binding site increases the
planarity of the heme moiety.
The structure of the complex of MPO with the SCN ion
(8) shows that the nitrogen atom is hydrogen-bonded to the
heme iron, whereas the sulfur atom is placed farther away
from the heme moiety. The shortest distance between any ni-
trogen atom of the heme group and the sulfur atom of the
SCN ion is more than 4.5 A˚. Although a comparable struc-
ture of LPO with the SCN ion at the distal site is not yet
available, the complex of the OSCN ion with LPO indicates
that the disposition of such a ligand in LPO and MPO may
differ significantly (Fig. 6). This may be attributable to a sig-
nificantly different local structural environment in the prox-
imity of the substrate-binding site in LPO, with an extensive
hydrogen-bonded network involving residues Gln-259, Gln-
105, Gln-102, and Leu-261 (Fig. 7). In contrast, the orienta-
tion of the side chain of Gln-91 in MPO is very different
from the side chain of the corresponding Gln-105 in LPO,
because the residues corresponding to Gln-259 and Leu-
261 in LPO are Met-243 and Glu-245, respectively, in
MPO, and are unsuitable for generating a hydrogen-bonded
network similar to that observed in LPO. Apart from this, in
place of the covalent bond formed between Met-243 and the
heme moiety in MPO, a hydrogen bond involving Gln-105
N32 and a pyrrole ring A nitrogen atom was observed in
LPO. Some other interactions (Fig. 8) involving pyrrole
ring D propionate were also found to be considerably differ-
FIGURE 7 Interactions involving OSCN ion and heme group in distal
heme cavity of LPO, as indicated by dashed line.
Structure of Lactoperoxidase Complexent in LPO and MPO. Yet another striking difference
pertains to the conformation of the loop 421–430, in the
proximity of the substrate-binding site and the heme moiety.
The corresponding loop is short and adopts a very different
conformation in MPO (9). These significant differences be-
tween the structures of MPO and LPO in the proximity of
the heme moiety and the distal site may be responsible for
the selection of different substrates. The perturbations in
planarities of heme moieties seem to result in different values
of the reduction potentials of various intermediates of LPO
and MPO (30). The values of standard reduction potentials
for compound I (ferric state) were found to be 1.16 V for
MPO, 1.10 V for EPO, and 1.09 V for LPO (30,31). The
corresponding value for TPO is not known.
In contrast to mammalian peroxidases, two binding sites in
plant peroxidases were detected: one is close to the g-heme
edge (32–34), whereas the more common second binding
site is located near the d-heme edge in the cavity that connects
the distal side of the heme to the surface of the protein (35–
38). The latter is similar to the binding site observed in mam-
malian peroxidases. The environments of distal histidine in
the plant peroxidases differ from those of mammalian perox-
idases, but the mechanisms of action are similar.
The authors acknowledge financial assistance from the Department of
Science and Technology (New Delhi, India). A.K.S. thanks the Council
of Scientific Industrial Research (New Delhi, India) for a Senior Research
Fellowship. T.P.S. thanks the Department of Biotechnology, Ministry of
Science and Technology (New Delhi, India) for a Distinguished Biotech-
nologist Award.
REFERENCES
1. Langbakk, B., and T. Flatmark. 1989. Lactoperoxidase from human
colostrum. Biochem. J. 259:627–631.
2. Harrison, J. E., and J. Schultz. 1976. Studies on the chlorinating activity
of myeloperoxidase. J. Biol. Chem. 251:1371–1374.
FIGURE 8 Some interactions are shown between protein residues in
proximity of heme group and with heme group, which are unique in LPO.
Biophysical Journal 96(2) 646–654
653
3. Wever, R., W. M. Kast, J. H. Kasinoedin, and R. Boelens. 1982. The
peroxidation of thiocyanate catalyzed by myeloperoxidase and lactoper-
oxidase. Biochim. Biophys. Acta. 709:212–219.
4. Bolscher, B. G., H. Plat, and R. Wever. 1984. Some properties of human
eosinophil peroxidase, a comparison with other peroxidases. Biochim.
Biophys. Acta. 784:177–186.
5. Kimura, S., T. Kotani, O. W. McBride, K. Umeki, K. Hirai, et al. 1987.
Human thyroid peroxidase: complete cDNA and protein sequence,
chromosome mapping, and identification of two alternately spliced
mRNAs. Proc. Natl. Acad. Sci. USA. 84:5555–5559.
6. Zeng, J., and R. E. Fenna. 1992. X-ray crystal structure of canine
myeloperoxidase at 3
A resolution. J. Mol. Biol. 226:185–207.
7. Fiedler, T. J., C. A. Davey, and R. E. Fenna. 2000. X-ray crystal
structure and characterization of halide-binding sites of human myelo-
peroxidase at 1.8 A˚ resolution. J. Biol. Chem. 275:11964–11971.
8. Blair-Johnson, M., T. Fiedler, and R. Fenna. 2001. Human myeloperox-
idase: structure of a cyanide complex and its interaction with bromide
and thiocyanate substrates at 1.9 A˚ resolution. Biochemistry.
40:13990–13997.
9. Singh, A. K., N. Singh, S. Sharma, S. B. Singh, P. Kaur, et al. 2008.
Crystal structure of lactoperoxidase at 2.4 A˚ resolution. J. Mol. Biol.
376:1060–1075.
10. Kumar, R., K. L. Bhatia, Z. Dauter, C. Betzel, and T. P. Singh. 1995.
Purification, crystallization and preliminary x-ray crystallographic anal-
ysis of lactoperoxidase from buffalo milk. Acta Crystallogr. D51:1094–
1096.
11. Frieden, E., and C. Walter. 1963. Prevalence and significance of the
product inhibition of enzymes. Nature. 198:834–837.
12. Cals, M. M., P. Mailliart, G. Brignon, P. Anglade, and B. R. Dumas.
1991. Primary structure of bovine lactoperoxidase, a fourth member
of a mammalian heme peroxidase family. Eur. J. Biochem. 198:733–
739.
13. Aune, T. M., and E. L. Thomas. 1977. Accumulation of hypothiocya-
nate ion during peroxidase-catalyzed oxidation of thiocyanate ion.
Eur. J. Biochem. 80:209–214.
14. Ellman, G. L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys.
82:70–77.
15. Aune, T. M., and E. L. Thomas. 1978. Oxidation of protein sulfhydryls
by products of peroxidase-catalyzed oxidation of thiocyanate ion.
Biochemistry. 17:1005–1010.
16. Laemmli, U. K. 1970. Cleavage of structural proteins during the assem-
bly of the head of bacteriophage T4. Nature. 227:680–685.
17. Colyer, J., and J. H. Wang. 1991. Dependence of cardiac sarcoplasmic
reticulum calcium pump activity on the phosphorylation status of phos-
pholamban. J. Biol. Chem. 266:17486–17493.
18. Otwinowski, Z., and W. Minor. 1997. Processing of x-ray diffrac-
tion data collected in oscillation mode. Methods Enzymol. 276:
307–326.
19. McCoy, A. J., R. W. Grosse-Kunstleve, L. C. Storoni, and R. J. Read.
2005. Likelihood-enhanced fast translation functions. Acta Crystallogr.
D61:458–464.
20. Murshudov, G. N., A. A. Vagin, and E. J. Dodson. 1997. Refinement of
macromolecular structures by the maximum likelihood method. Acta
Crystallogr. D53:240–255.
654Biophysical Journal 96(2) 646–65421. CCP4. 1994. Collaborative Computational Project. Number 4. The
CCP4 suite: programs for protein crystallography. Acta Crystallogr.
D50:760–763.
22. Jones, T. A., J. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved
methods for building models in electron density maps and the location
of errors in these models. Acta Crystallogr. A. 47:110–118.
23. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for
molecular graphics. Acta Crystallogr. D60:2126–2132.
24. Ramachandran, G. N., and V. Sasisekaran. 1968. Conformation of
polypeptides and proteins. Adv. Protein Chem. 23:283–438.
25. Laskowski, R. A., M. Macarthur, D. Moss, and J. Thornton. 1993.
PROCHECK: a program to check stereo chemical quality of protein
structures. J. Appl. Cryst. 26:283–290.
26. Reiter, B., and G. Harnulv. 1984. Lactoperoxidase antimicrobial sys-
tem: natural occurrence, biological functions and practical applications.
J. Food Prot. 47:724–732.
27. Bjorck, L. 1978. Antimicrobial effect of the lactoperoxidase system on
psychotropic bacteria in milk. J. Dairy Res. 45:109–118.
28. Kuti, M., J. Rabai, I. Kapovits, I. Jalsovszky, G. Argay, et al. 1996.
Transannular sulfur-nitrogen interaction in 1,5-thiazocine derivatives:
an x-ray study. J. Mol. Struct. 382:1–11.
29. Morokuma, K., M. Hanamura, and K. Akiba. 1984. Role of sulfur d or-
bitals in the S-N bond stability of ammonioalkylsulfuranes. Chem. Lett.
(Jpn.). 13:1556–1560.
30. Furtmuller, P. G., J. Arnhold, W. Jantschko, M. Zederbauer, C. Jako-
pitsch, et al. 2005. Standard reduction potentials of all couples of the
peroxidase cycle of lactoperoxidase. J. Inorg. Biochem. 99:1220–1229.
31. Arnhold, J., P. G. Furtmuller, G. Regelsberger, and C. Obinger. 2001.
Redox properties of the couple compound I/native enzyme of myeloper-
oxidase and eosinophil peroxidase. Eur. J. Biochem. 268:5142–5148.
32. Sharp, K. H., M. Mewies, P. C. Moody, and E. L. Raven. 2003. Crystal
structure of the ascorbate peroxidase-ascorbate complex. Nat. Struct.
Biol. 10:303–307.
33. Sundaramoorthy, M., K. Kishi, M. H. Gold, and T. L. Poulos. 1994. The
crystal structure of manganese peroxidase from Phanerochaete chryso-
sporium at 2.06 A˚ resolution. J. Biol. Chem. 269:32759–32767.
34. Poulos, T. L. 2007. The Janus nature of heme. Nat. Prod. Rep. 24:504–
510.
35. Metcalfe, C., I. K. Macdonald, E. J. Murphy, K. A. Brown, E. L. Raven,
et al. 2008. The tuberculosis prodrug isoniazid bound to activating per-
oxidases. J. Biol. Chem. 283:6193–6200.
36. Kunishima, N., K. Fukuyama, H. Matsubara, H. Hatanaka, Y. Shibano,
et al. 1994. Crystal structure of the fungal peroxidase from Arthromyces
ramosus at 1.9 A˚ resolution. Structural comparisons with the lignin and
cytochrome c peroxidases. J. Mol. Biol. 235:331–344.
37. Poulos, T. L., S. T. Freer, R. A. Alden, S. L. Edwards, U. Skogland,
et al. 1980. The crystal structure of cytochrome c peroxidase. J. Biol.
Chem. 255:575–580.
38. Henriksen, A., D. J. Schuller, K. Meno, K. G. Welinder, A. T. Smith,
et al. 1998. Structural interactions between horseradish peroxidase C
and the substrate benzhydroxamic acid determined by x-ray crystallog-
raphy. Biochemistry. 37:8054–8060.
39. DeLano, W. L. 2002. The PyMol Molecular Graphics System. DeLano
Scientific, San Carlos, CA. http://www.pymol.org.
Singh et al.
